Microangiopathic hemolytic anemia causes: Difference between revisions
Jump to navigation
Jump to search
MydahSajid (talk | contribs) |
MydahSajid (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} {{AE}} {{MSJ}} | ||
==Overview== | ==Overview== | ||
[[Microangiopathic hemolytic anemia]] is a clinical manifestation of a large number of [[disease]]s. | [[Microangiopathic hemolytic anemia]] is a clinical manifestation of a large number of [[disease]]s. |
Revision as of 20:36, 31 January 2021
Microangiopathic hemolytic anemia Microchapters |
Differentiating Microangiopathic hemolytic anemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Microangiopathic hemolytic anemia causes On the Web |
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia causes |
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
Risk calculators and risk factors for Microangiopathic hemolytic anemia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mydah Sajid, MD[2]
Overview
Microangiopathic hemolytic anemia is a clinical manifestation of a large number of diseases.
Causes
The most important causes are[1]:
- Aortic Stenosis (most common cause of MAHA)
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Disseminated intravascular coagulation (DIC)
- Drug Side Effect- Cyclosporine
- HELLP syndrome and eclampsia
- Heparin-induced thrombocytopenia (HIT)
- Severe glomerulonephritis
- Several other rare causes
References
- ↑ Kottke-Marchant K (2017). "Diagnostic approach to microangiopathic hemolytic disorders". Int J Lab Hematol. 39 Suppl 1: 69–75. doi:10.1111/ijlh.12671. PMID 28447417.